Viewing Study NCT06433869


Ignite Creation Date: 2025-12-24 @ 10:54 PM
Ignite Modification Date: 2025-12-29 @ 3:25 PM
Study NCT ID: NCT06433869
Status: RECRUITING
Last Update Posted: 2024-05-30
First Post: 2024-04-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Efficacy of Bevacizumab and Serplulimab Combined With Recombinant Mutant HumanTumor Necrosis Factor(rmhTNF-NC) in the Treatment of Malignant Ascites
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module